Applied Fish Pharmacology
|
|
- Silas Cook
- 5 years ago
- Views:
Transcription
1 Applied Fish Pharmacology
2 AQUACULTURE Volume3 1. Fish Nutrition in Aquaculture Sena S. De Silva and Trevor A. Anderson ISBN X 2. Environmental Management for Aquaculture Alex Midlen and Theresa Redding ISBN
3 Applied Fish Pharmacology K. M. Treves-Brown MA, Vet MB ( Cantab ), Master of Arts, Bachelor of Veterinary Medicine, Cambridge University MRCVS, Member of the Royal College ofveterinary Surgeons, London SPRINGER-SCIENCE+BUSINESS MEDIA, B.V.
4 Library of Congress Cataloging-in-Publication Data ISBN ISBN (ebook) DOI / Printed on acid-free paper Ali Rights Reserved 2000 Springer Science+Business Media Dordrecht Originally published by Kluwer Academic Publishers in 2000 N o part of the material protected by this copyright notice may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording or by any information storage and retrieval system, without written permission from the copyright owner.
5 SERIES EDITOR'S PREFACE Fish culture is a growing agribusiness. Considering the value of that business, the frequency and often devastating nature of fish diseases, it is perhaps surprising that a comprehensive text explaining the pharmacology of fish medicines has not been available until now. In the space of little over 300 pages, some 22 Chapters have been organised into four parts: General Considerations (3 Chapters); Antibacterial Drugs (8 Chapters); Other Chemotherapeutic Agents (4 Chapters) and Pharmacodynamic Agents (7 Chapters). Keith Treves-Brown is to be congratulated on producing a comprehensive yet readable text on a topic few have ventured to touch on to date. An explanation of the pharmacology of fish medicines is indeed long overdue and I feel sure that Keith Treves-Brown's book will be a source used by Fish Health Managers for many years to come. Indeed, I fully expect it to become a part of the essential reference collection on a great many fish farms. Veterinarians specialising in fish diseases will fmd it invaluable. Students studying fish diseases, whether as part of a general aquaculture course or as a specialist subject, will also wish to have access to it. Post-graduates will fmd it a constant source of much useful information, as I am sure will managers working in 'Regulatory Agencies'. While Keith Treves-Brown's experience and examples are naturally European, the topic of 'Applied Fish Pharmacology' has a universal appeal and this book should be of great value throughout the world of fish culture. As such it is a very welcome addition to the 'Aquaculture Book Series'. Michael G. Poxton Editor, Aquaculture Series
6 CONTENTS ACKNOWLEDGEMENTS xi PREFACE xiii PART ONE GENERAL CONSIDERATIONS CHAPTER 1 - Methods of Drug Administration Water medication In-feed medication Gavage Injection Topical application 15 CHAPTER 2 - Safety of Fish Medicines Aspects of safety Safety to the target species Safety to the operator Safety to the consumer Safety to the environment 22 CHAPTER 3 - The Law The aims of legislation Labelling Drug usage outwith MA provisions Legal control of in-feed medication Environmental safety legislation Consumer safety- Regulation 2377/90/EEC Market authorizations Future developments 50
7 viii PART TWO ANTIBACTERIAL DRUGS CHAPTER 4 - Comparative Aspects Introduction Selection of antibacterial drugs Environmental safety Bacterial resistance 61 CHAPTER 5 - Tetracyclines Group characteristics Uses of oxytetracycline Pharmacokinetics of oxytetracycline Pharmacodynamics of oxytetracycline Oxytetracycline in the environment Other tetracyclines 81 CHAPTER 6 - Penicillins Group characteristics Uses Dose rates Pharmacokinetics 85 CHAPTER 7 - Macrolides Group characteristics Pharmacokinetics.of erythromycin Toxicology of erythromycin Control of bacterial kidney disease Other macrolides 94 CHAPTER 8 - Sulfonamides Group characteristics Pharmacokinetics 96 CHAPTER 9 - Potentiated sulfonamides Group characteristics Pharmacokinetics 112 CHAPTER 10 - Quinolones and Fluoroquinolones Group characteristics Nalidixic acid Oxolinic acid Pirornidic acid Flumequine Other ftuoroquinolones 137
8 ix CHAPTER 11 - Other Systemic Antibacterial Agents 11.1 Nitrofurans 11.2 Chloramphenicol 11.3 Florfenicol PART THREE OTHER CHEMOTHERAPEUTIC AGENTS CHAPTER 12 - Systemic Anti-protozoal Agents 12.1 Fumagillin 12.2 Nitroimidazoles CHAPTER 13 - Externally applied antimicrobial agents 13.1 Formalin 13.2 Malachite green 13.3 Leteux-Meyer mixture 13.4 Chloramine-T 13.5 Copper sulfate CHAPTER 14 - Ectoparasiticides 14.1 Metazoan ectoparasites 14.2 Organo-phosphorus compounds 14.3 Hydrogen peroxide 14.4 Ivermectin 14.5 Cypermethrin 14.6 Benzyl-ureas CHAPTER 15 - Anthelmintics 15.1 Worm parasites of fish 15.2 Flukicides 15.3 Tapeworm and roundworm treatments PART FOUR PHARMACODYNAMIC AGENTS CHAPTER 16 - Anaesthetics 16.1 General considerations 16.2 MS Benzocaine 16.4 Other anaesthetic agents 16.5 Hypnotics and sedatives
9 X CHAPTER 17 - Breeding induction agents Reproductive physiology Drugs used in breeding induction Procedures for individual species 230 CHAPTER 18 - Sex control The objectives of sex control Induction of triploidy Medicinal production of all-female populations Sex control in tilapia Production of sterile carp Induction of sex change in hermaphrodite species Safety Aspects 249 CHAPTER 19 - Immuno-stimulants Immuno-modulation Glucans Other immuno-stimulants 256 CHAPTER 20 - Vaccines Evaluation Routes of administration Available vaccines 271 CHAPTER 21 - Osmoregulators Physiological osmo-regulation Medicinal osmo-regulation 277 CHAPTER 22 - Disinfectants Uses of disinfectants Chemical disinfectants 282 APPENDICES I Trade marks of products specifically formulated for use in fish 289 II Linnean and English names of cultured species of finfish 293 III Glossary 297 INDEX 299
10 ACKNOWLEDGEMENTS Advice on chapters on which they have particular expertise has been freely given to me by Dr. David Alderman of The Centre for Environment, Fisheries and Aquaculture Science (CEFAS) and Mr. Edward Branson, MRCVS. All the other chapters have been reviewed by my son, Dr. Bernard Treves-Brown, a chemist; and he has produced the chemical formulae which are the subject of several of my figures. My wife, Ruth, has produced computer print-outs of over 20 tables. I am grateful to them all for the time and attention they have given. Mrs. Sue Walker, librarian at CEFAS, has been unfailingly patient and helpful, not only during my many visits to her library but also on the innumerable occasions when I have telephoned and asked her to drop everything and look up an odd point in a journal for me.
11 PREFACE In writing a book with any technical content at all one has to decide what degree of prior knowledge the reader will bave. This book is intended to be of worldwide application, and it is hoped that it will prove of interest to numerous people in fish farm management and also some involved with other aspects of aquaculture such as the supply of ornamental fish. This means that the hoped-for readership will have wide variations in prior knowledge both qualitatively and quantitatively. As a veterinarian myself I have chosen as the person to whom to address the book a newly qualified veterinarian. I am assuming that he or she will be very well versed in the medicine of homoiotherms, but know very little about poikilothermic vertebrates despite their great, and increasing, importance as sources of protein for mankind. This means I am assuming considerable understanding of the different types of medicines used by veterinarians, but occasionally pointing out some aspects of fish behaviour and physiology, particularly osmo-regulation, which non-veterinarian readers may regard as elementary. Above all one must keep emphasizing the fundamental importance of temperature to the rate of biochemical, including pharmacological, processes. This book is about what is known, not what is legal. Readers who are aware of my previous employment in the Veterinary Medicines Directorate (V.M.D.), the UK government regulatory body, may be surprised at my advocating medicinal applications which are illegal in UK. Three points need to be made: first, I am not advocating but stating what has been reported; secondly, even though something is illegal in one or a few countries it is probably legal in many others, and thirdly, law is continually changing. In the last context it must be remarked that the European Union legislators have acknowledged that current medicines law is unsatisfactory in its application to fish; and significant changes have been made to the procedures for determining maximum residue limits in fish tissues during the time taken to write this book. Another group who may be surprised at my writing this book are the active fish pharmacologists. I am not one; in fact I am happy to admit that I have never done any laboratory or field research in my life. I have nevertheless spent most of my career studying veterinary pharmacological research reports and deciding what they prove in terms of justifiable claims and necessary warnings and precautions for veterinary medicinal products. I have done this in pharmaceutical industry, writing many labels and directionsfor-use leaflets which have been widely used and translated into many languages; I have done the same thing in V.M.D., and I have done the same thing again in writing this book. Many fish pharmacologists may notice their results quoted selectively and sometimes without acknowledgement. To address the second point first, the fact is that a majority of readers would not study research papers in the scientific literature even if the references were given. Those who read references are research workers who wish either to use the same techniques or to dispute the conclusions; this book is not primarily intended for them.
12 xiv The first word of the title is 'Applied' because I have aimed to cover those pharmacological data, and only those data, which can be used in the prevention and treatment of fish disease or the enhancement of fish productivity. Where I have listed research reports under 'Further Reading' I believe the reader can obtain additional information relevant to the aims of the book. In keeping with those aims I have tended to use units which modem scientific purists will regard as old-fashioned. My experience leads me to believe that to be easily read is more important than to be scientifically fashionable, and where dose rates are concerned clarity is paramount. To the veterinarian in practice and to the fish farmer I believe 'mg/kg/day' is preferable to 'mg.kg- 1.d- 1 ', and 'ppm' obviates problems of whether to use 'mg/kg' or 'J.Lg/g' (or should it be ' 1 6g 0 -. g - ~ Even '? ). scientists {both authors and reviewers) sometimes get confused by the modem notation: one paper listed in this book gives the units of the concentration of azamethiphos in water correctly as mg.l- 1 on three occasions and wrongly as 'mg- 1.L' on over 40 occasions! Another foreseeable criticism of this book is that it is patchy in its coverage of the subject- some aspects are covered extensively and some not at all. This is regrettably true; it reflects the available data. Two aspects of the research reports I have read have been disappointing to one with the particular interests I hold. I have read at times of elegant and pains-taking research which does not have any obvious application. How many studies have been made of elimination half-lives of residues of drugs in serum or plasma? We do not drink fish blood; we eat the musculature! How often do we read computer calculations to many significant figures of transference rates of drugs to deep or superficial compartments of a fish? The equations may give remarkable correlations with observed plasma concentrations but what the clinician needs to know is the identity of the tissues or organs represented by those compartments. A small volume of distribution is relevant, albeit negative, information for the clinician; a large volume of distribution says nothing - is the drug widely distributed at low concentration or is it selectively concentrated in one organ? The second disappointment is the narrow range of fish species and drugs on which research has been concentrated. The former is perhaps inevitable; well-equipped and well-staffed laboratories tend to be in places where salmonids or channel catfish are the predominant farmed species, although one must not overlook the important work the Japanese have done with the ayu and yellowtail. Nevertheless it is extraordinary how much has been published about oxytetracycline, a rather unsuitable antibiotic for in-feed administration to fish, and how little has been published about amoxycillin which seems to me to be far superior. There is much more literature about oxolinic acid than about flumequine, but it is the latter which now has an MRL assigned in the EU*. I hope this book will help veterinarians to prescribe wisely and fish farmers to administer drugs safely and effectively. Although I have written that the book is not primarily intended for research pharmacologists I hope it will help them to concentrate their attentions where they are most needed. *An MRL has recently been assigned to oxolinic acid.
ANTIMICROBIAL USAGE IN AQUACULTURE
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries ANTIMICROBIAL USAGE IN AQUACULTURE Review of AMU in aquaculture based
More informationSales survey of veterinary medicinal products containing antimicrobials in France in Annual report
Sales survey of veterinary medicinal products containing antimicrobials in France in 2016 Annual report October 2017 Scientific edition Sales survey of veterinary medicinal products containing antimicrobials
More informationSales survey of Veterinary Medicinal Products containing Antimicrobials in France Volumes and estimated exposure of animals to antimicrobials
Sales survey of Veterinary Medicinal Products containing Antimicrobials in France - 2013 Volumes and estimated exposure of animals to antimicrobials October 2014 Scientific Edition Sales survey of Veterinary
More informationFurther memorandum submitted by the Department for Environment, Food and Rural Affairs
Further memorandum submitted by the Department for Environment, Food and Rural Affairs Follow-up to the evidence session on 5 November 2008: [Bee research] I am writing in response to your letter of 10
More informationBeef Producers. The Judicious Use of Antimicrobials for
The Judicious Use of Antimicrobials for Beef Producers Introduction The production of safe and wholesome animal products for human consumption is a primary goal of beef producers. To achieve that goal,
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cephacare flavour 50 mg tablets for cats and dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active
More informationESSENTIALS OF ANTIMICROBIAL PHARMACOLOGY
ESSENTIALS OF ANTIMICROBIAL PHARMACOLOGY Essentials of Antimicrobial Pharmacology A Guide to Fundamentals for Practice PAUL H. AXELSEN, MD University of Pennsylvania School of Medicine Philadelphia, PA
More informationSome Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified)
Some Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified) (Note: many chemicals have been used at one time or another to combat bacterial disease in koi. We have attempted
More informationGuidance for completing the OIE template for the collection of data on antimicrobial agents intended for use in animals
Guidance for completing the OIE template for the collection of data on antimicrobial agents intended for use in animals Contents Introduction... 1 Required information and choices for reporting... 2 Baseline
More informationAct 101 of 1965 Medicines and Related Substances Control Act. Pharmacology of Fish: Basic Principles
Pharmacology of Fish: Basic Principles David Huchzermeyer Sterkspruit Veterinary Clinic Act 101 of 1965 Medicines and Related Substances Control Act Governs use of antibiotics and hormones. Available on
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Zubrin 50 mg oral lyophilisates for dogs Zubrin 100 mg oral lyophilisates for dogs Zubrin 200 mg oral lyophilisates
More informationAntimicrobials and Scottish salmonid aquaculture
Antimicrobials and Scottish salmonid aquaculture Catherine Collins, Una McCarthy & Sandy Murray FSA-AMR presentation 25 th Nov. 2016, London Scottish aquaculture production Species No. individuals Marine
More informationAquaculture Drugs: Industry Concerns
Washington DC New York Denver Seattle Aquaculture Drugs: Industry Concerns Lisa Weddig Vice President, Regulatory and Technical Affairs National Fisheries Institute Who is NFI? Leading advocacy organization
More informationThe OIE Manual of Diagnostic Tests and Vaccines for Terrestrial & Aquatic Animals
The OIE Manual of Diagnostic Tests and Vaccines for Terrestrial & Aquatic Animals Regional seminar for OIE National Focal Points for Veterinary Products, Tokyo, Japan, 3-5 December 2014 Barbara Freischem,
More informationPRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 13 to 15 July 2004
European Medicines Agency Veterinary Medicines and Inspections London, 16 July 2004 EMEA/CVMP/713/04/Rev 1 PRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 13 to 15 July 2004
More informationruma Cattle Responsible use of antimicrobials in Cattle production GUIDELINES
ruma RESPONSIBLE USE OF MEDICINES IN AGRICULTURE ALLIANCE GUIDELINES Cattle Responsible use of antimicrobials in Cattle production RUMA guidelines for the responsible use of antimicrobials by cattle farmers
More informationThe Beagle Brain in Stereotaxic Coordinates
The Beagle Brain in Stereotaxic Coordinates Xavier Palazzi The Beagle Brain in Stereotaxic Coordinates Xavier Palazzi Sanofi-Aventis 3, Digue d Alfortville 94140 Alfortville France xavier.palazzi@sanofi-aventis.com
More informationEuropean Public MRL assessment report (EPMAR)
18 March 2016 EMA/CVMP/619817/2015 Committee for Medicinal Products for Veterinary Use European Public MRL assessment report (EPMAR) Gentamicin (all mammalian food producing species and fin fish) On 3
More informationEurEau s Contribution to the European Commission s Strategic Approach on Veterinary Pharmaceuticals in the Environment
EurEau s Contribution to the European Commission s Strategic Approach on Veterinary Pharmaceuticals in the Environment Summary Globally, pharmaceutical products are regularly administered to both livestock
More informationSUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NUFLOR 300 mg/ml solution for injection for cattle and sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:
More informationCommittee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018
7 December 2017 Committee for Medicinal Products for Veterinary Use (CVMP) Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018 Chairpersons Chair: D. Murphy Status Adopted in December
More informationResponsible use of antimicrobials in veterinary practice
Responsible use of antimicrobials in veterinary practice Correct antimicrobial: as little as possible, as much as necessary This document provides more information to accompany our responsible use of antimicrobials
More informationAntimicrobials and Scottish salmonid aquaculture. FSA-AMR presentation 25 th Nov. 2016, London
Antimicrobials and Scottish salmonid aquaculture FSA-AMR presentation 25 th Nov. 2016, London Scottish aquaculture production Species Tonnage No. individuals No. sites No. businesses Salmon (SW) 171,722
More informationTerrestrial and Aquatic Manuals and mechanism of standard adoption
Regional Seminar OIE National Focal Points for Veterinary Products Tokyo, Japan 2 4 March 2016 Terrestrial and Aquatic Manuals and mechanism of standard adoption Dr Maria Szabo Scientific and Technical
More informationSmall Animal Oncology
Small Animal Oncology Small Animal Oncology Joanna Morris Formerly of Department of Clinical Veterinary Medicine, University of Cambridge Veterinary School and Jane Dobson Department of Clinical Veterinary
More informationFLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER
FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER 1. NAME OF THE VETERINARY MEDICINAL PRODUCT FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance:
More informationAtlas of Experimental Toxicological Pathology
Atlas of Experimental Toxicological Pathology To Cora P. Cherry for sharing with us her wealth of experience in the field of toxicological pathology Current Histopathology Consultant Editor Professor G.
More informationSales survey of Veterinary Medicinal Products containing Antimicrobials in France
Sales survey of Veterinary Medicinal Products containing Antimicrobials in France - 2009 February 2011 Édition scientifique Sales survey of Veterinary Medicinal Products containing Antimicrobials in France
More informationCFA Veterinary Residues Management Guidance
CFA Veterinary Residues Management Guidance Kaarin Goodburn Food Safety & Technology Management Consultant Chilled Food Association www.chilledfood.org Programme Support and endorsement Need for Guidance?
More informationBSc, PhD, MBA, LLM, MSc (Med Sci), DAgVetPharm, FRPharmS, FCPP, FIPharmM, MPS (NZ), FNZCP, FFHom
Veterinary Pharmacy Edited by Steven B Kayne BSc, PhD, MBA, LLM, MSc (Med Sci), DAgVetPharm, FRPharmS, FCPP, FIPharmM, MPS (NZ), FNZCP, FFHom Independent Consultant Pharmacist and Visiting Lecturer, School
More informationSOUTH AFRICAN NATIONAL STANDARD
ISBN 978-0-626-35881-5 SOUTH AFRICAN NATIONAL STANDARD Pet food Nutritional and manufacturing requirements WARNING This document references other documents normatively. Published by the South African Bureau
More informationAntibiotics A Multidisciplinary Approach
Antibiotics A Multidisciplinary Approach Antibiolies A Multidisciplinary Approach Giancarlo Lancini Marion Merrell Dow Research Institute (MMDRI) Lepetit Research Center Gerenzano (Varese), Italy Francesco
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Marbocare 20 mg/ml solution for injection for cattle and pigs (UK, IE, FR) Odimar 20 mg/ml solution for injection for cattle
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC FOR ANTIMICROBIAL PRODUCTS
European Medicines Agency Veterinary Medicines and Inspections London, 12 November 2007 EMEA/CVMP/SAGAM/383441/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC
More informationThe Responsible Use of Medicines in Agriculture Alliance (RUMA) Role and Activities
The Responsible Use of Medicines in Agriculture Alliance (RUMA) Role and Activities John FitzGerald RUMA Secretary General AHDA, Birmingham 28 January 2014 Today Why RUMA? Who is RUMA? What does RUMA do
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT CYTOPOINT 10 mg solution for injection for dogs CYTOPOINT 20 mg solution for injection for dogs CYTOPOINT 30 mg
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE
European Medicines Agency Veterinary Medicines and Inspections EMEA/CVMP/211249/2005-FINAL July 2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE DIHYDROSTREPTOMYCIN (Extrapolation to all ruminants)
More informationHerbal Medicine for Animal Use in JAPAN
Herbal Medicine for Animal Use in JAPAN Quality Assay Section, Assay Division Ⅱ, National Veterinary Assay Laboratory 21 Dec. 2016 6 Oct. 2016 1 Veterinary Drugs Veterinary Drugs Veterinary Pharmaceuticals
More informationAgvet Chemicals Task Group Veterinary Prescribing and Compounding Rights Working Group
Agvet Chemicals Task Group Veterinary Prescribing and Compounding Rights Working Group Submission from the Australian Veterinary Association Ltd www.ava.com.au The Australian Veterinary Association Limited
More informationVisit ABLE on the Web at:
This article reprinted from: Lessem, P. B. 2008. The antibiotic resistance phenomenon: Use of minimal inhibitory concentration (MIC) determination for inquiry based experimentation. Pages 357-362, in Tested
More informationTerrestrial and Aquatic Manuals and mechanism of standard adoption
Regional Seminar OIE National Focal Points for Veterinary Products Entebbe, Uganda, 1 3 December 2015 Terrestrial and Aquatic Manuals and mechanism of standard adoption Dr Francois Diaz Scientific and
More informationVeterinary Medicine Master s Degree Day-One Skills
Veterinary Medicine Master s Degree Day-One Skills Professional general attributes and capacities The newly-graduated veterinarian must: 1- Know the national and European ethic and professional regulations
More informationCopyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and
Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere
More informationNo July 2000 REGULATION. respecting veterinarians authorisations to prescribe drugs SECTION II
REGULATION respecting veterinarians authorisations to prescribe drugs SECTION I Scope and definitions Article 1 This Regulation contains special provisions applying to veterinarians authorisations to prescribe
More informationAntibiotics. Simplified. Jason C. Gallagher PharmD, BCPS. Conan MacDougall PharmD, MAS, BCPS. Clinical Associate Professor Temple University
Antibiotics Simplified third EDITION Jason C. Gallagher PharmD, BCPS Conan MacDougall PharmD, MAS, BCPS Clinical Associate Professor Temple University Associate Professor of Clinical Pharmacy School of
More informationEuropean public MRL assessment report (EPMAR)
15 January 2013 EMA/CVMP/914694/2011 Committee for Medicinal Products for Veterinary Use (CVMP) European public MRL assessment report (EPMAR) Fenbendazole (extension to chicken and extrapolation to all
More informationSUMMARY OF PRODUCT CHARACTERISTICS
[Version 8, 10/2012] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS (Based on the current SPC of the reference product Baytril RSI 100 mg/ml Injektionslösung für Rinder und Schweine) 1 1. NAME OF THE VETERINARY
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Credelio 56 mg chewable tablets for dogs (1.3 2.5 kg) Credelio 112 mg chewable tablets for dogs (>2.5 5.5 kg) Credelio
More informationAntibiotics use and Considerations: Calves and Heifers CLASSIFICATION OF CALVES. Danielle A. Mzyk TITLE 24 PT. ARIAL BOLD ALL CAPS
CALF AND HEIFER CONGRESS - 2016 Antibiotics use and Considerations: Calves and Heifers Danielle A. Mzyk TITLE 24 PT. ARIAL BOLD ALL CAPS Today s Presentation Classification of Calves Define Preruminant
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate
SUMMARY OF PRODUCT CHARACTERISTICS AN: 00221/2013 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Lincocin Forte S Intramammary Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Lincomycin
More informationV E T E R I N A R Y C O U N C I L O F I R E L A N D ETHICAL VETERINARY PRACTICE
V E T E R I N A R Y C O U N C I L O F I R E L A N D ETHICAL VETERINARY PRACTICE ETHICAL VETERINARY PRACTICE The term Ethical Veterinary Practice is a wide ranging one, implying as it does, compliance with
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Amphen 200 mg/g Granules for use in drinking water for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each g contains: Active
More informationThe use of antimicrobials in livestock production and antimicrobial resistance in pathogens from livestock
The use of antimicrobials in livestock production and antimicrobial resistance in pathogens from livestock Dr. W K de Silva Director General Department of Animal Production and Health Production 2011 Milk
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ophtocycline 10 mg/g eye ointment for dogs, cats and horses (AT, BE, BG, CY, CZ, EL, ES, HR, HU, IE, IT, LU, NL,
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Amfipen LA 100 mg/ml suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Each ml contains:
More informationMedicines for bees. Establishment of maximum residue limits. Principles for marketing authorisations
Medicines for bees Establishment of maximum residue limits Principles for marketing authorisations Presented by: Isaura Duarte Head of Animal and Public Health; Veterinary Medicines Sector An agency of
More informationWorkshop on Strengthening livestock health and Veterinary Services. Kiev, 2-3 November 2010 TAIEX, AGR 42266
Workshop on Strengthening livestock health and Veterinary Services Kiev, 2-3 November 2010 TAIEX, AGR 42266 1 Session III: Overview Veterinary Medicines Legislation in the EUROPEAN UNION Nancy De Briyne
More informationPart II SUMMARY OF PRODUCT CHARACTERISTICS. Each tablet contains 25 mg Clindamycin (as Clindamycin Hydrochloride)
Clindacyl 25mg Tablets Vm 08007/4104 Part II SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT CLINDACYL 25 MG TABLETS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMP/627/01-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE DEMONSTRATION OF EFFICACY
More informationB. PACKAGE LEAFLET 1
B. PACKAGE LEAFLET 1 PACKAGE LEAFLET NICILAN 400 mg/100 mg tablets for dogs 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
More informationCODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE CAC/RCP Adopted 2005
CODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE CAC/RCP 61-2005 Adopted 2005 CAC/RCP 61-2005 2 1. INTRODUCTION 2. AIMS AND OBJECTIVES 3. RESPONSIBILITIES OF THE REGULATORY AUTHORITIES
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Xylacare 2% w/v Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Qualitative composition
More informationGUIDANCE FOR VETERINARY SURGEONS. Use of norethisterone for oestrus suppression in racing bitches in Great Britain
GUIDANCE FOR VETERINARY SURGEONS Use of norethisterone for oestrus suppression in racing bitches in Great Britain The Veterinary Medicines Directorate (VMD) has confirmed that norethisterone, an authorised
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Selectan 300 mg/ml solution for injection for cattle and swine. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Acecare 2mg/ml Solution for Injection for Dogs and Cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of solution contains
More informationIntroduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018
Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.
More informationPoultry Science Journal ISSN: (Print), (Online)
Madadi et al., 2014 25 Poultry Science Journal ISSN: 2345-6604 (Print), 2345-6566 (Online) http://psj.gau.ac.ir Evaluation of Drug Interactions and Prescription Errors of Poultry Veterinarians in North
More informationPost malachite green: Alternative strategies for fungal infections and white spot disease
Bull. Eur. Ass. Fish Pathol., 22(2) 2002, 152 Post malachite green: Alternative strategies for fungal infections and white spot disease R. Rahkonen 1 and P. Koski 2 1 Finnish Game and Fisheries Research
More informationVeterinary Feed Directive: What You Need to Know
Iowa Farm Bureau s Margin Management Webinar Series presents: Veterinary Feed Directive: What You Need to Know Are you prepared for implementation of the Veterinary Feed Directive on January 1, 2017? Introduction:
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT WONDERCEF powder and solvent for solution for injection for horses not intended for the production of foods for human consumption.
More informationIrish Medicines Board
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (No. 2) REGULATIONS 2007 (S.I. No. 786 of 2007) VPA: 10999/056/001 Case No: 7004318 The Irish Medicines Board in exercise of the powers
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/MRL/728/00-FINAL April 2000 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS STREPTOMYCIN AND
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12 1. NAME OF THE VETERINARY MEDICINAL PRODUCT HALOCUR 0.5 mg/ml oral solution for calves 2. Qualitative and quantitative composition Active substance Halofuginone
More informationPRESS RELEASE COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections London, 20 June 2003 PRESS RELEASE COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS Meeting of 17 to 19 June
More informationThis document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
1996L0022 EN 18.12.2008 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COUNCIL DIRECTIVE 96/22/EC of 29 April 1996 concerning
More informationRUMA: Advocating Prudent Use of Antimicrobial Compounds
RUMA: Advocating Prudent Use of Antimicrobial Compounds John FitzGerald Responsible Use of Medicines in Agriculture (RUMA) Alliance Antimicrobial Resistance: A Whole Food Chain Approach How should Ireland
More informationThis document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
1996L0022 EN 18.12.2008 002.001 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COUNCIL DIRECTIVE 96/22/EC of 29 April 1996 concerning
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Rycarfa 100 mg tablets for dogs (BE, DE, ES, FR, IE, IT, NL, PT, UK) Rycarfa vet 100 mg tablets for dogs (DK, FI) Carprox
More informationMSc in Veterinary Education
MSc in Veterinary Education The LIVE Centre is a globally unique powerhouse for research and development in veterinary education. As its name suggests, its vision is a fundamental transformation of the
More informationCOMMISSION NOTICE Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) Table of Contents
11.9.2015 EN Official Journal of the European Union C 299/7 COMMISSION NOTICE Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) Table of Contents Introduction... 7
More informationEXPERIENCE ON ANTIMICROBIAL USE AND RESISTANCE IN KENYA
EXPERIENCE ON ANTIMICROBIAL USE AND RESISTANCE IN KENYA PRESENTED BY DR. NATHAN K. SONGOK National Focal Point Veterinary Medicinal Products Kenya At the Regional Seminar for OIE National Focal Points
More informationSUMMARY of PRODUCT CHARACTERISTICS
SUMMARY of PRODUCT CHARACTERISTICS 1. Name of the veterinary medicinal product HELM-EX Flavour Tablets 2. Qualitative and quantitative composition Each tablet contains: Active ubstances Praziquantel 50.0
More informationChemical Inputs from Salmon Aquaculture
Chemical Inputs from Salmon Aquaculture Dr. Les Burridge, Fisheries and Oceans Canada Dr. Judith Weis, Rutgers University Dr. Felipe Cabello, New York Medical College Dr. Jaime Pizarro, University of Santiago
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Panacur AquaSol 200 mg/ml oral suspension for use in drinking water for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationQuality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products
Quality of Veterinary Medicinal Products How to ensure the quality of Veterinary Medicinal Products Gérard Moulin Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products gerard.moulin@anses.fr
More informationMARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS
MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MARBOCYL 10%, solution for injection for cattle and swine 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Marbofloxacin...100.0
More informationCOUNCIL REGULATION (EEC) No 2377/90
-W- -- 18. 8. 90 Official Journal of the ~uroiean Communities No L 224/P - - (Acts whose publication is obligatory) COUNCIL REGULATION (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure
More informationAntimicrobial use in animals: OIE collection of data on antimicrobial agents used in animals (2015)
Antimicrobial use in animals: OIE collection of data on antimicrobial agents used in animals (2015) OIE antimicrobialuse team with the support of Dr Gérard Moulin ESVAC Stakeholders annual meeting London,
More informationAerial view of the Faculty of Veterinary Medicine Utrecht
Aerial view of the Faculty of Veterinary Medicine Utrecht The role of a veterinarian in the next 30 years Anton Pijpers Utrecht University Content What s happening around us In general Societal demands
More informationUse of Antibiotics in Ornamental Fish Aquaculture 1
Cir 84 1 Roy P. E. Yanong 2 Introduction Antibiotics are very useful additions to any fish-health manager s toolbox, but they are only tools and not magic bullets. The ability of antibiotics to help eliminate
More informationAntimicrobial resistance in food safety perspective - current situation in Croatia
Antimicrobial resistance in food safety perspective - current situation in Croatia Ivana Lohman Janković, DVM Ministry of Agriculture, Fisheries and Rural Development Veterinary Directorate Human and Veterinary
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Metrobactin 500 mg tablets for dogs and cats (AT, BE, BG, CY, CZ, DE, EL, ES, FR, HR, HU, IE, IT, LU, NL, PL, PT, RO, SI,
More information1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Summary of Prodcuct Characteristics 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Enrox Max 100 mg/ml Solution for Injection for Cattle and Pigs Enroxal Max 100 mg/ml Solution for Injection for Cattle and
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Distocur 34 mg/ml Oral suspension for cattle. Distocur.vet 34 mg/ml Oral suspension for cattle. (DK, NO, SE) 2.
More informationHaving regard to the Treaty establishing the European Community, and in particular Article 152(4)(b) thereof,
14.10.2003 L 262/17 DIRECTIVE 2003/74/EC OF THE EUROPEAN PARLIAMT AND OF THE COUNCIL of 22 September 2003 amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain
More informationCommunity Approaches. Feral Cats. by Margaret R. Slater HUMANE SOCIETY PRESS PUBLIC POLICY SERIES
Community Approaches TO Feral Cats HUMANE SOCIETY PRESS P R O B L E M S, A L T E R N A - T I V E S, & R E C O M M E N - D A T I O N S PUBLIC POLICY SERIES by Margaret R. Slater Community Approaches TO
More informationANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS
ANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS PHM025D March 2016 Neha Maliwal Project Analyst ISBN: 1-62296-252-4 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationSmall Animal Medicine
2017 AUSTRALIAN AND NEW ZEALAND COLLEGE OF VETERINARY SCIENTISTS MEMBERSHIP GUIDELINES Small Animal Medicine INTRODUCTION These Membership Guidelines should be read in conjunction with the Membership Candidate
More informationAmerican Association of Feline Practitioners American Animal Hospital Association
American Association of Feline Practitioners American Animal Hospital Association Basic Guidelines of Judicious Therapeutic Use of Antimicrobials August 1, 2006 Introduction The Basic Guidelines to Judicious
More informationVeterinary medicines. Prescriptions 2. Dispensing veterinary medicines 3. Storage of poisons and restricted substances 5
Veterinary medicines Prescriptions 2 Dispensing veterinary medicines 3 Storage of poisons and restricted substances 5 Labelling and packaging prescriptions 7 1 Prescriptions A prescription refers to the
More information